SAPA Awards:
Sino-American Pharmaceutical Professionals Association (SAPA) awards selected academic and industry leaders in the Pharmaceutical & Biotechnology field for their achievements and contribution in innovative research, healthcare advancement, product development, mentorship and education in the SAPA Annual Conferences every year.
2022 SAPA Distinguished Achievement Awards
Prof. David MacMillan, PhD, James S. McDonnell Distinguished University Professor of Chemistry, Princeton University, 2021 Nobel Laureate in Chemistry
Dr. Dean Y. Li, MD, PhD, EVP and president, Merck Research Laboratories
Appendix I: Historic Awardees
SAPA Distinguished Leadership in Life Science and Healthcare Award
2020: Mr. Kenneth C. Frazier, Chairman and Chief Executive Officer, Merck & Co., Inc
SAPA Distinguished Achievement Awardees in 2018-2021
2021: Prof. Kenneth Kaitin, PhD, MS, Professor and Senior Fellow, Center for the Study of Drug Development, Tufts University School of Medicine
2020: Prof. Yibin Kang, PhD, Warner-Lambert/Parke-Davis Professor of Molecular Biology, Princeton University; Associate Director, Rutgers Cancer Institute of New Jersey; President, Chinese Biological Investigator Society
2020: Dr. Litao Zhang, PhD, Global Head of Discovery Technology and Molecular Pharmacology (DTMP), Janssen Pharmaceuticals (Johnson & Johnson)
2019: Dr. Xiaodong Wang, Director of National Institute of Biological Sciences and Co-Founder of Beigene, Beijing, China
2019: Dr. Lawrence X. Yu, Deputy Director, Office of Pharmaceutical Quality at CEDR, FDA
2018: Prof. David Ho, Rockefeller University, CEO of Aaron Diamond AIDS Research Center
2018: Dr. Ge Li, Founder and CEO, Wuxi AppTec
SAPA Lifetime Achievement Awardees in 2018-2020
2020: Prof. Virginia Man-Yee Lee, PhD, John H. Ware 3rd Professor in Alzheimer’s Research, Director of the Center for Neurodegenerative Disease Research and Co-Director of the Marian S. Ware Alzheimer Drug Discovery Program, University of Pennsylvania
2020: Dr. P. Roy Vagelos, MD, Retired Chairman & CEO, Merck & Co, Inc., Chairman of the Board, Regeneron Pharmaceuticals, Inc.
2019: Prof. Martin Chalfie, Nobel Laureate, Columbia University
2018: Prof. Joachim Frank, Nobel Laureate, Columbia University
Appendix II:
Selected Speakers of Annual Conferences:
Academia:
Prof. Dudley Herschbach, Nobel Laureate, Harvard University
Prof. Jack Szostak, Nobel Laureate, Harvard Medical School
Prof. Craig Mello, Nobel Laureate, University of Massachusetts Medical Center
Prof. Bruce Beutler, Nobel Laureate, University of Texas Southwestern Medical Center
Prof. K. Barry Sharpless, Nobel Laureate, Scripps Research Institute
Prof. Baruch S. Blumberg, Nobel Laureate, Fox Cancer Center
Prof. Ferenc Avraham Hershko, Nobel Laureate, Israel Institute of Technology
Prof. Yigong Shi, Dean of Life Science, Tsinghua University, Beijing, China
Industry & Government:
Dr. Binodh DeSilva, PhD, Vice President, Leads Development & Optimization, Bristol Myers Squibb
Dr. Kevin Campos, PhD, Vice President and Head of Process Research and Development, Merck & Co, Inc.
Dr. John Tsai, MD, Head of Global Drug Development and CMO, Novartis
Dr. Jay Mei, PhD, Founder, Chairman & CEO, Antengene Corporation
Dr. Nianfeng (Oliver) Ju, MBA, Chairman & CEO, Board office of Porton Pharma Solutions Ltd.
Dr. Dalvir Gill, PhD, CEO, TransCelerate Biopharma Inc.
Mr. Simon Trowell, VP, Quality & Risk Management, Clinical Operations, Pharmaceutical R&D, GSK; Chair of TransCelerate Clinical Oversight Committee
Dr. Rupert Vessey, PhD, EVP and President, Research and Early Development, Bristol Myers Squibb
Dr. Peter Stein, MD, Director, CDER, Office of New Drugs, Immediate Office, US FDA
Dr. Peter Marks, Director, CBER, US FDA
Dr. Theresa Mullin, Director, office of strategic program, FDA/CDER and Chair of ICH management committee
Dr. Dean Li, MD, PhD, SVP, Discovery Science and Translational Medicine, Merck Research Laboratories
Dr. Mathai Mammen, MD, PhD, Global Head of R&D, Janssen Pharmaceutical Companies of Johnson & Johnson
Dr. Andrew Chan, MD, PhD, Senior VP Research Biology, Genentech
Dr. Josh Ghaim, CTO, Johnson & Johnson, Family of Consumer Companies
Dr. Axel Hoos, Senior Vice President, Oncology R&D, GSK
Dr. Sandra Leung, Executive Vice President, General Counsel and Corporate Secretary, BMS
Mr. Isaac Blech, Managing Director, 21st Century Investors Group
Dr. Mathias Hukkelhoven, Senior Vice President, Bristol-Myers Squibb
Dr. David Lebwohl, Senior Vice President, Novartis
Dr. Deborah Dunsire, CEO, Millennium-Takeda
Dr. Cathryn Clary, Head, US Medical & Chief Scientific Officer, Novartis Pharmaceuticals
Dr. Joe Camardo, Senior Vice President, Global Medical Affairs, Celgene Corporation
Dr. Michele Cleary, VP, Head of Clinical Translational Technologies & Operations, Bristol-Myers Squibb
Dr. Paul Deutsch, VP, Head of Translational Medicine & Early Development, Sanofi
Dr. JC Gutierrez-Ramos, Senior Vice President, Chief Scientific Officer, Pfizer
Dr. Ronald Krall, Sr. VP, World Wide Development and Chief Medical Officer, GlaxoSmithKline
Dr. Rich Tillyer, Sr. VP, Head of Discovery & Preclinical Sciences, Merck Research Laboratories
Dr. Lee Babiss, Head of Global Pharma Research, Roche
Dr. Robert R. Ruffalo, President, Wyeth Research
Dr. Alan Palkowitz, VP, Discovery Chemistry Research & technology, Eli Lilly & Company
Dr. Dequan Ren, Deputy Commissioner, State Food and Drug Administration of China (SFDA)
Dr. Stephen Wilson, Director, Division of Biometrics, FDA
Dr. Greg Geba, Former Director, Office of Generic Drugs at CDER, FDA
Dr. Joshua Ghaim, Chief Technology Officer, Johnson & Johnson Family of Consumer Companies
Mr. Lawrence Y. Tian, Chairman, CIFCO International Group